<DOC>
	<DOC>NCT00283556</DOC>
	<brief_summary>The purpose of this study is to compare the response to treatment and side effects associated with high dose irinotecan in patients with recurrent brain tumors.</brief_summary>
	<brief_title>High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma</brief_title>
	<detailed_description>This is a phase I/II study of high dose irinotecan in patients with recurrent unresectable malignant glioma on steroids/anti-epileptics. The purpose is to compare the response to treatment and side effects associated with high dose irinotecan in patients with recurrent brain tumors.</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>recurrent, unresectable primary CNS neoplasm per MRI ECOG status of 2 or less no prior therapy with camptothecans on an enzymeinducing antiepileptic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>High Dose Irinotecan</keyword>
	<keyword>CPT-11</keyword>
	<keyword>Camptosar</keyword>
	<keyword>Malignant Glioma</keyword>
	<keyword>Unresectable</keyword>
</DOC>